Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
LIDAL, a Time-of-Flight Radiation Detector for the International Space Station: Description and Ground Calibration.
Romoli G, Di Fino L, Santi Amantini G, Boretti V, Lunati L, Berucci C, Messi R, Rizzo A, Albicocco P, De Donato C, Masciantonio G, Morone MC, Nobili G, Baiocco G, Mentana A, Pullia M, Tommasino F, Carrubba E, Bardi A, Passerai M, Castagnolo D, Mascetti G, Crisconio M, Narici L. Romoli G, et al. Among authors: bardi a. Sensors (Basel). 2023 Mar 28;23(7):3559. doi: 10.3390/s23073559. Sensors (Basel). 2023. PMID: 37050619 Free PMC article.
Radiation measurements in the International Space Station, Columbus module, in 2020-2022 with the LIDAL detector.
Di Fino L, Romoli G, Santi Amantini G, Boretti V, Lunati L, Berucci C, Messi R, Rizzo A, Albicocco P, De Donato C, Masciantonio G, Morone MC, Nobili G, Baiocco G, Mentana A, Pullia M, Tommasino F, Carrubba E, Bardi A, Passerai M, Castagnolo D, Mascetti G, Crisconio M, Matthiä D, Narici L. Di Fino L, et al. Among authors: bardi a. Life Sci Space Res (Amst). 2023 Nov;39:26-42. doi: 10.1016/j.lssr.2023.03.007. Epub 2023 May 6. Life Sci Space Res (Amst). 2023. PMID: 37945086
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients.
Rigolin GM, Traversa A, Caputo V, Del Giudice I, Bardi A, Saccenti E, Raponi S, Ilari C, Cafforio L, Giovannetti A, Pizzuti A, Guarini A, Foà R, Cuneo A. Rigolin GM, et al. Among authors: bardi a. Br J Haematol. 2023 Sep;202(5):953-959. doi: 10.1111/bjh.18946. Epub 2023 Jun 26. Br J Haematol. 2023. PMID: 37357817
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia.
Cafforio L, Raponi S, Cappelli LV, Ilari C, Soscia R, De Propris MS, Mariglia P, Rigolin GM, Bardi A, Peragine N, Piciocchi A, Arena V, Mauro FR, Cuneo A, Guarini A, Foa R, Del Giudice I. Cafforio L, et al. Among authors: bardi a. Haematologica. 2022 Jan 1;107(1):334-337. doi: 10.3324/haematol.2020.263715. Haematologica. 2022. PMID: 34647439 Free PMC article. No abstract available.
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Rigolin GM, Del Giudice I, Bardi A, Melandri A, García-Jacobo RE, Cura F, Raponi S, Ilari C, Cafforio L, Piciocchi A, Arena V, Reda G, Albano F, Molica S, Sportoletti P, Trentin L, Marchetti M, Nanni M, Peragine N, Mariglia P, Vignetti M, Guarini A, Mauro FR, Foà R, Cuneo A. Rigolin GM, et al. Among authors: bardi a. Blood. 2021 Dec 23;138(25):2727-2730. doi: 10.1182/blood.2021011883. Blood. 2021. PMID: 34587233 Free article. Clinical Trial. No abstract available.
102 results